Author [ Keyword(Desc)] Title Type Year
Filters: Author is Schätzlein, Andreas  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Gunaratnam M, de la Fuente M, Hampel SM, Todd AK, Reszka AP, Schätzlein A, Neidle S.  2011.  Targeting pancreatic cancer with a G-quadruplex ligand.. Bioorg Med Chem. 19(23):7151-7.
Cevc G, Schätzlein A, Richardsen H.  2002.  Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements.. Biochim Biophys Acta. 1564(1):21-30.
Siew A, Le H, Thiovolet M, Gellert P, Schätzlein A, Uchegbu I.  2012.  Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles.. Mol Pharm. 9(1):14-28.
Garrett NLaura, Lalatsa A, Uchegbu I, Schätzlein A, Moger J.  2012.  Exploring uptake mechanisms of oral nanomedicines using multimodal nonlinear optical microscopy.. J Biophotonics. 5(5-6):458-68.
Rahman KM, Jackson PJM, James CH, B Basu P, Hartley JA, de la Fuente M, Schätzlein A, Robson M, R Pedley B, Pepper C et al..  2013.  GC-targeted C8-linked pyrrolobenzodiazepine-biaryl conjugates with femtomolar in vitro cytotoxicity and in vivo antitumor activity in mouse models.. J Med Chem. 56(7):2911-35.
Welsh SJ, Dale AG, Lombardo CM, Valentine H, de la Fuente M, Schätzlein A, Neidle S.  2013.  Inhibition of the hypoxia-inducible factor pathway by a G-quadruplex binding small molecule.. Sci Rep. 3:2799.